A 67-Year-Old-Man with Metastatic Prostate Cancer - Episode 3
Stephen J. Freedland, MD, explains the treatment regimen he would have chosen for the patient with mCRPC in the presented case and outlines which factors, including clinical data, inform his treatment decision-making.